Adherence to subcutaneous anti‐TNFα agents in patients with rheumatoid arthritis is largely influenced by pain and skin sensations at the injection site-Reference-Cited by-同舟云学术

Adherence to subcutaneous anti‐TNFα agents in patients with rheumatoid arthritis is largely influenced by pain and skin sensations at the injection site

Published:2020-03-02 Issue:4 Volume:23 Page:480-487
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Salaffi Fausto¹^ORCID,Di Carlo Marco¹^ORCID,Farah Sonia¹^ORCID,Carotti Marina²^ORCID

Affiliation:

1. Rheumatological Clinic Ospedale “Carlo Urbani” Università Politecnica delle Marche Jesi (Ancona) Italy

2. Department of Radiology Ospedali Riuniti Università Politecnica delle Marche Ancona Italy

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.13803

Reference51 articles.

1. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community‐based study. I. The MAPPING study;Salaffi F;Clin Exp Rheumatol,2005

2. Rheumatoid arthritis and the era of biologic therapy

3. The anti‐tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritis;Haraoui B;J Rheumatol Suppl,2005

4. National Institute for Health and Care Excellence.Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence;https://www.nice.org.uk/guidance/cg76/chapter/1-Guidance#patient-involvement-in-decisions-about-medicines. Accessed January 28 2009.

5. Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence to the antirheumatic drugs: a systematic review and meta-analysis;Frontiers in Medicine;2024-09-12

2. Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasis;Expert Opinion on Drug Safety;2024-08-17

3. Relevance of Adalimumab Product Attributes to Patient Experience in the Biosimilar Era: A Narrative Review;Advances in Therapy;2024-03-11

4. Patient self-reported experience and satisfaction with golimumab and etanercept treatments for rheumatic diseases: A cohort study;Medicine;2024-02-23

5. The Adherence and Outcomes Benefits of Using a Connected, Reusable Auto-Injector for Self-Injecting Biologics: A Narrative Review;Advances in Therapy;2023-09-21